In a patient with carotid artery stenosis status post stenting, should I continue aspirin (acetylsalicylic acid) 325 mg daily indefinitely?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ASA 325 mg in Carotid Stenosis Post-Stenting

After carotid artery stenting, you should reduce aspirin from 325 mg to 81 mg daily after the initial post-stenting period (typically 1-3 months) and continue aspirin indefinitely at this lower maintenance dose.

Post-Stenting Antiplatelet Strategy

Initial Period (First 1-3 Months)

  • Dual antiplatelet therapy (DAPT) is standard: aspirin 325 mg daily PLUS clopidogrel 75 mg daily 1
  • This intensive regimen reduces periprocedural thrombotic complications
  • Duration depends on stent type: typically 4-6 weeks for single-layer stents, up to 3 months for mesh stents 2

Long-Term Maintenance (After Initial Period)

Transition to aspirin monotherapy at 81 mg daily and continue indefinitely 3, 1

The evidence strongly supports this dose reduction:

  • Lower doses (81 mg) are as effective as higher doses (325 mg) for long-term stroke prevention while reducing bleeding risk 4, 3
  • Guidelines consistently recommend 75-162 mg daily for chronic maintenance after the initial high-dose period 5
  • The 2014 AHA/ACC guidelines specifically state aspirin maintenance dose should be 81 mg daily in most patients 3

Key Clinical Considerations

Why Reduce the Dose?

Higher aspirin doses (>325 mg) increase bleeding risk without additional thrombotic protection in the chronic phase 6. The initial higher dose (325 mg) is used peri-procedurally when thrombotic risk is highest, but this elevated risk diminishes after the first few months.

Bleeding Risk Assessment

If your patient has high bleeding risk (age >75, weight <60 kg, history of GI bleeding, concurrent anticoagulation), consider:

  • Earlier transition to 81 mg daily (potentially after 1 month rather than 3 months)
  • Adding a proton pump inhibitor for GI protection 3
  • More frequent monitoring

When to Continue Higher Doses

The only scenario to maintain 325 mg long-term would be if the patient has recurrent thrombotic events despite standard therapy, but this is uncommon and should prompt investigation for aspirin resistance or other prothrombotic conditions.

Common Pitfalls to Avoid

  1. Don't continue 325 mg indefinitely - this unnecessarily increases bleeding risk without proven benefit after the initial post-stenting period
  2. Don't stop aspirin entirely - lifelong antiplatelet therapy is essential for secondary stroke prevention 1, 2
  3. Don't use aspirin alone during the initial 1-3 months - DAPT is critical during this high-risk period 1, 2

The evidence is clear: reduce to 81 mg daily for long-term maintenance after the initial post-stenting period, and continue indefinitely for optimal stroke prevention with minimal bleeding risk.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.